SEC recommends Phase 1 clinical trials of Reliance’s Covid vaccine candidate

Earlier, Mukesh Ambani-owned Reliance Life Sciences had sought approval for the Phase I trial of its proposed two-dose vaccine

This post was originally published on The Asian Age | Home.